Allergan Continues to Grow Medical Aesthetics Franchise with Exicure Deal

By Michelle Liu

Pharma Deals Review: Vol 2019 Issue 11 (Table of Contents)

Published: 20 Nov-2019

DOI: 10.3833/pdr.v2019.i11.2469     ISSN: 1756-7874

Section: Licensing



While its merger with AbbVie is being finalised, Allergan has partnered with clinical-stage biotech company, Exicure, to develop treatments for hair loss disorders utilising Exicure’s proprietary SNA™ (spherical nucleic acid) technology...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details